4 insiders reported 10 Form 4 transactions for Celldex Therapeutics, Inc. (CLDX) over the past 18 months (most recent 2026-01-06). Recent activity: Martin Samuel Bates (SVP AND CFO) Buy 4,817 shares, PEPIN RONALD (SR. VP & CBO) Buy 8,333 shares, PEPIN RONALD (SR. VP & CBO) Buy 11,000 shares, Jimenez Freddy A. (SVP & GENERAL COUNSEL) Sell 4,166 shares, Wright Richard M. (Insider) Buy 6,876 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-01-06 | Martin Samuel Bates | SVP AND CFO | Buy | 4,817 | $50,000 |
| 2025-12-17 | PEPIN RONALD | SR. VP & CBO | Buy | 8,333 | $75,164 |
| 2025-12-17 | PEPIN RONALD | SR. VP & CBO | Buy | 11,000 | $30,580 |
| 2025-12-08 | Jimenez Freddy A. | SVP & GENERAL COUNSEL | Sell | 4,166 | $121,231 |
| 2025-11-17 | Wright Richard M. | Insider | Buy | 6,876 | $62,022 |
| 2025-11-17 | Wright Richard M. | Insider | Buy | 26,672 | $276,855 |
| 2025-11-17 | Wright Richard M. | Insider | Buy | 15,750 | $354,060 |
| 2025-11-17 | Wright Richard M. | Insider | Sell | 49,298 | $1.2M |
| 2025-08-15 | Jimenez Freddy A. | SVP & GENERAL COUNSEL | Sell | 341 | $8,167 |
| 2025-08-15 | Jimenez Freddy A. | SVP & GENERAL COUNSEL | Sell | 430 | $10,931 |
Source: SEC Form 4 filings · as of 2026-01-06